Beijing Tiantan Biological Products Co., Ltd.
600161
Rangering i aksjer
#4321
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and... Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.
Aksjekurs
$1.81
Markedsverdi
$3.59B
Endring (1 dag)
-0.90%
Endring (1 år)
-32.39%
Land
CN
Handel Beijing Tiantan Biological Products Co., Ltd. (600161)
Kategori
Healthcare
Historikk for aksjesplitt for Beijing Tiantan Biological Products Co., Ltd. (600161)
Aksjen Beijing Tiantan Biological Products Co., Ltd. (symbol: 600161) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 22, 2026.
Én 600161-aksje kjøpt før Oct 22, 2026 tilsvarer i dag 0 600161-aksjer.
Den nyeste splittelsen skjedde Oct 22, 2026.
Én 600161-aksje kjøpt før Oct 22, 2026 tilsvarer i dag 0 600161-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
